| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.577 | 0.005 | 0.577 | Anesthetic general | 0.347 0.024 CID_27492 | ||
| 0.563 | 0.003 | 0.563 | Alcohol oxidase inhibitor | 0.175 0.008 CID_27492 | ||
| 0.564 | 0.012 | 0.564 | GABA C receptor rho-3 antagonist | 0.474 0.033 CID_27492 | ||
| 0.556 | 0.009 | 0.556 | Anticonvulsant | |||
| 0.557 | 0.019 | 0.557 | 5 Hydroxytryptamine release stimulant | 0.281 0.076 CID_27492 | ||
| 0.521 | 0.026 | 0.521 | 5 Hydroxytryptamine release inhibitor | 0.261 0.213 CID_27492 | ||
| 0.508 | 0.025 | 0.508 | Calcium channel L-type activator | |||
| 0.498 | 0.023 | 0.498 | Spasmolytic | |||
| 0.471 | 0.037 | 0.471 | Aldehyde oxidase inhibitor | 0.156 0.134 CID_27492 | ||
| 0.436 | 0.015 | 0.436 | RNA-directed DNA polymerase inhibitor | 0.318 0.028 CID_27492 | ||
| 0.425 | 0.008 | 0.425 | Alpha-N-acetylglucosaminidase inhibitor | 0.364 0.011 CID_27492 | ||
| 0.426 | 0.019 | 0.426 | DNA synthesis inhibitor | 0.366 0.027 CID_27492 | ||
| 0.405 | 0.008 | 0.405 | Tyrosine 3 hydroxylase inhibitor | 0.251 0.067 CID_27492 | ||
| 0.4 | 0.022 | 0.4 | Psychostimulant | 0.212 0.074 CID_27492 | ||
| 0.389 | 0.029 | 0.389 | Calcium channel activator | 0.268 0.127 CID_27492 | ||
| 0.42 | 0.065 | 0.42 | Histamine release inhibitor | |||
| 0.384 | 0.032 | 0.384 | Cardiotonic | |||
| 0.407 | 0.058 | 0.407 | Calpain 2 inhibitor | 0.202 0.185 CID_27492 | ||
| 0.379 | 0.033 | 0.379 | DNA damaging | 0.183 0.131 CID_27492 | ||
| 0.38 | 0.042 | 0.38 | Vasodilator, coronary | |||
| 0.389 | 0.052 | 0.389 | Cholesterol antagonist | 0.202 0.163 CID_27492 | ||
| 0.325 | 0.008 | 0.325 | Succinate dehydrogenase inhibitor | 0.307 0.01 CID_27492 | ||
| 0.346 | 0.029 | 0.346 | Peroxidase inhibitor | 0.164 0.071 CID_27492 | ||
| 0.408 | 0.093 | 0.408 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.366 0.133 CID_27492 | ||
| 0.323 | 0.01 | 0.323 | Anesthetic local | 0.302 0.012 CID_27492 | ||
| 0.346 | 0.037 | 0.346 | Superoxide dismutase inhibitor | 0.309 0.047 CID_27492 | ||
| 0.338 | 0.037 | 0.338 | Transcription factor STAT3 inhibitor | 0.234 0.097 CID_27492 | ||
| 0.337 | 0.039 | 0.337 | Transcription factor STAT inhibitor | 0.207 0.129 CID_27492 | ||
| 0.382 | 0.085 | 0.382 | Antibacterial | 0.354 0.1 CID_27492 | ||
| 0.304 | 0.009 | 0.311 | Antineoplastic antibiotic | 0.311 0.009 CID_27492 | CID_27492 | |
| 0.356 | 0.062 | 0.356 | Antithrombotic | 0.205 0.172 CID_27492 | ||
| 0.295 | 0.004 | 0.295 | Carbamoyl phosphate synthetase inhibitor | 0.191 0.008 CID_27492 | ||
| 0.298 | 0.013 | 0.298 | Alkylator | 0.18 0.033 CID_27492 | ||
| 0.319 | 0.036 | 0.322 | 5 Hydroxytryptamine uptake stimulant | 0.322 0.035 CID_27492 | CID_27492 | |
| 0.279 | 0.011 | 0.279 | UDP-glucose 4-epimerase inhibitor | 0.158 0.026 CID_27492 | ||
| 0.271 | 0.013 | 0.271 | Cell wall synthesis inhibitor | 0.183 0.038 CID_27492 | ||
| 0.263 | 0.007 | 0.263 | Calcium antagonist | |||
| 0.258 | 0.003 | 0.258 | Acetylcholine M3 receptor agonist | 0.191 0.005 CID_27492 | ||
| 0.267 | 0.015 | 0.267 | Aldehyde dehydrogenase inhibitor | 0.153 0.045 CID_27492 | ||
| 0.299 | 0.048 | 0.299 | Vasodilator | 0.253 0.067 CID_27492 | ||
| 0.26 | 0.012 | 0.26 | 5 Hydroxytryptamine 3E antagonist | 0.222 0.035 CID_27492 | ||
| 0.256 | 0.012 | 0.256 | ATPase inhibitor | 0.215 0.027 CID_27492 | ||
| 0.254 | 0.013 | 0.254 | GABA C receptor agonist | 0.254 0.013 CID_27492 | ||
| 0.248 | 0.007 | 0.32 | Triose-phosphate isomerase inhibitor | 0.32 0.004 CID_27492 | CID_27492 | |
| 0.247 | 0.009 | 0.253 | Microtubule formation inhibitor | 0.253 0.008 CID_27492 | CID_27492 | |
| 0.251 | 0.013 | 0.273 | Ferrochelatase inhibitor | 0.273 0.01 CID_27492 | CID_27492 | |
| 0.244 | 0.007 | 0.244 | GABA C receptor antagonist | 0.171 0.021 CID_27492 | ||
| 0.247 | 0.012 | 0.247 | Catenin beta inhibitor | 0.164 0.077 CID_27492 | ||
| 0.261 | 0.026 | 0.261 | Nitric-oxide synthase stimulant | 0.177 0.134 CID_27492 | ||
| 0.257 | 0.023 | 0.257 | Acetylcholine M1 receptor antagonist | 0.124 0.103 CID_27492 | ||
| 0.244 | 0.013 | 0.244 | GABA C receptor rho-2 antagonist | 0.174 0.047 CID_27492 | ||
| 0.232 | 0.01 | 0.232 | Catalase inhibitor | 0.146 0.027 CID_27492 | ||
| 0.22 | 0.003 | 0.22 | Acetylcholine M2 receptor agonist | 0.088 0.01 CID_27492 | ||
| 0.266 | 0.051 | 0.266 | Calpain inhibitor | 0.195 0.118 CID_27492 | ||
| 0.216 | 0.004 | 0.216 | Protease 3C (Human rhinovirus) inhibitor | 0.12 0.01 CID_27492 | ||
| 0.242 | 0.032 | 0.242 | Diuretic | |||
| 0.217 | 0.008 | 0.217 | Adenylate cyclase stimulant | 0.196 0.015 CID_27492 | ||
| 0.212 | 0.004 | 0.212 | Acyl-CoA dehydrogenase inhibitor | 0.113 0.014 CID_27492 | ||
| 0.211 | 0.007 | 0.211 | GABA C receptor rho-1 antagonist | 0.153 0.02 CID_27492 | ||
| 0.221 | 0.017 | 0.221 | Antibacterial (Helicobacter pylori) | |||
| 0.216 | 0.013 | 0.267 | Adenylate kinase inhibitor | 0.267 0.009 CID_27492 | CID_27492 | |
| 0.208 | 0.005 | 0.208 | Acetylcholine muscarinic agonist | |||
| 0.241 | 0.04 | 0.241 | Insulin sensitizer | |||
| 0.215 | 0.015 | 0.215 | Nav1.6 sodium channel blocker | |||
| 0.206 | 0.016 | 0.206 | GABA receptor agonist | |||
| 0.26 | 0.071 | 0.26 | Interleukin agonist | |||
| 0.191 | 0.003 | 0.191 | Acetylcholine M5 receptor agonist | 0.075 0.039 CID_27492 | ||
| 0.272 | 0.088 | 0.272 | Immunostimulant | 0.16 0.147 CID_27492 | ||
| 0.297 | 0.117 | 0.297 | Immunosuppressant | |||
| 0.216 | 0.035 | 0.216 | Phospholipase C inhibitor | 0.176 0.065 CID_27492 | ||
| 0.183 | 0.003 | 0.183 | Exportin-1 inhibitor | 0.143 0.004 CID_27492 | ||
| 0.183 | 0.005 | 0.183 | Glutamate release inhibitor | |||
| 0.194 | 0.02 | 0.194 | Nav1.4 sodium channel blocker | 0.144 0.037 CID_27492 | ||
| 0.195 | 0.024 | 0.195 | Cathepsin H inhibitor | 0.166 0.036 CID_27492 | ||
| 0.177 | 0.006 | 0.177 | Ornithine decarboxylase inhibitor | 0.12 0.026 CID_27492 | ||
| 0.206 | 0.037 | 0.206 | Thiol protease inhibitor | 0.143 0.077 CID_27492 | ||
| 0.238 | 0.07 | 0.238 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.172 | 0.005 | 0.172 | Acetylcholine M1 receptor agonist | |||
| 0.18 | 0.014 | 0.18 | Sphingomyelinase inhibitor | |||
| 0.199 | 0.034 | 0.199 | Arachidonic acid antagonist | 0.158 0.08 CID_27492 | ||
| 0.255 | 0.092 | 0.255 | Insulysin inhibitor | 0.221 0.128 CID_27492 | ||
| 0.208 | 0.047 | 0.208 | 3C-like protease (Human coronavirus) inhibitor | 0.182 0.064 CID_27492 | ||
| 0.176 | 0.019 | 0.176 | Acetylcholine agonist | 0.093 0.052 CID_27492 | ||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.144 0.06 CID_27492 | ||
| 0.157 | 0.005 | 0.157 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.05 CID_27492 | ||
| 0.165 | 0.013 | 0.165 | Glutamate dehydrogenase inhibitor | 0.137 0.018 CID_27492 | ||
| 0.18 | 0.03 | 0.182 | Acetylcholine muscarinic antagonist | 0.182 0.029 CID_27492 | CID_27492 | |
| 0.192 | 0.042 | 0.192 | Heat shock protein 90 antagonist | |||
| 0.161 | 0.014 | 0.222 | Factor V inhibitor | 0.222 0.004 CID_27492 | CID_27492 | |
| 0.156 | 0.009 | 0.198 | Ornithine carbamoyltransferase inhibitor | 0.198 0.007 CID_27492 | CID_27492 | |
| 0.15 | 0.004 | 0.15 | Glutamate (mGluR6) antagonist | 0.086 0.018 CID_27492 | ||
| 0.154 | 0.008 | 0.154 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.129 0.01 CID_27492 | ||
| 0.174 | 0.029 | 0.174 | Aminopeptidase B inhibitor | 0.118 0.054 CID_27492 | ||
| 0.175 | 0.03 | 0.175 | Cyclooxygenase 3 inhibitor | |||
| 0.159 | 0.018 | 0.159 | Histidine decarboxylase inhibitor | 0.067 0.054 CID_27492 | ||
| 0.158 | 0.017 | 0.201 | Phosphofructokinase-1 inhibitor | 0.201 0.011 CID_27492 | CID_27492 | |
| 0.164 | 0.024 | 0.164 | Carbonic anhydrase III inhibitor | |||
| 0.163 | 0.024 | 0.163 | Photosensitizer | 0.13 0.046 CID_27492 | ||
| 0.211 | 0.074 | 0.211 | Platelet aggregation inhibitor | |||
| 0.142 | 0.009 | 0.142 | GABA aminotransferase inhibitor | 0.127 0.013 CID_27492 | ||
| 0.255 | 0.124 | 0.255 | Transcription factor NF kappa B inhibitor | |||
| 0.144 | 0.013 | 0.144 | Phenylalanine 4-hydroxylase inhibitor | 0.088 0.032 CID_27492 | ||
| 0.159 | 0.028 | 0.159 | Mucolytic | 0.095 0.086 CID_27492 | ||
| 0.232 | 0.101 | 0.232 | Gastrin inhibitor | |||
| 0.13 | 0.003 | 0.13 | Acetylcholine M4 receptor agonist | 0.027 0.025 CID_27492 | ||
| 0.15 | 0.024 | 0.15 | Creatine kinase inhibitor | 0.089 0.073 CID_27492 | ||
| 0.144 | 0.019 | 0.144 | NADH dehydrogenase inhibitor | 0.104 0.039 CID_27492 | ||
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.129 0.067 CID_27492 | ||
| 0.172 | 0.047 | 0.172 | Hemostatic | |||
| 0.17 | 0.047 | 0.17 | Nav1.2 sodium channel blocker | |||
| 0.197 | 0.074 | 0.197 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.151 | 0.029 | 0.151 | Protease inhibitor | 0.11 0.056 CID_27492 | ||
| 0.164 | 0.044 | 0.164 | Toll-Like receptor 2 antagonist | 0.114 0.085 CID_27492 | ||
| 0.122 | 0.003 | 0.122 | Glutamate (mGluR1) agonist | 0.038 0.006 CID_27492 | ||
| 0.126 | 0.013 | 0.126 | Toll-Like receptor 2 agonist | |||
| 0.126 | 0.013 | 0.129 | Biliverdin reductase inhibitor | 0.129 0.012 CID_27492 | CID_27492 | |
| 0.134 | 0.021 | 0.134 | Toll-Like receptor 3 antagonist | |||
| 0.302 | 0.191 | 0.302 | Caspase 9 stimulant | 0.273 0.225 CID_27492 | ||
| 0.14 | 0.03 | 0.14 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.137 0.031 CID_27492 | ||
| 0.158 | 0.048 | 0.205 | Cholinergic antagonist | 0.205 0.03 CID_27492 | CID_27492 | |
| 0.181 | 0.071 | 0.181 | Amyloid beta precursor protein antagonist | |||
| 0.134 | 0.024 | 0.167 | Porphobilinogen synthase inhibitor | 0.167 0.017 CID_27492 | CID_27492 | |
| 0.14 | 0.034 | 0.14 | Carbonic anhydrase XV inhibitor | |||
| 0.154 | 0.048 | 0.204 | Acetylcholine antagonist | 0.204 0.03 CID_27492 | CID_27492 | |
| 0.155 | 0.053 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.141 | 0.04 | 0.141 | DNA repair enzyme inhibitor | |||
| 0.168 | 0.067 | 0.168 | Anticoagulant | |||
| 0.149 | 0.048 | 0.149 | Nav1.3 sodium channel blocker | |||
| 0.126 | 0.025 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.141 | 0.042 | 0.141 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.106 | 0.007 | 0.106 | Aconitate hydratase inhibitor | 0.061 0.025 CID_27492 | ||
| 0.157 | 0.058 | 0.157 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.114 | 0.016 | 0.122 | Argininosuccinate synthase inhibitor | 0.122 0.015 CID_27492 | CID_27492 | |
| 0.119 | 0.021 | 0.119 | Histamine H2 receptor antagonist | |||
| 0.121 | 0.024 | 0.121 | GABA A receptor agonist | |||
| 0.109 | 0.013 | 0.109 | NMDA receptor glycine site agonist | |||
| 0.123 | 0.029 | 0.123 | Potassium channel (Voltage-sensitive) activator | |||
| 0.116 | 0.022 | 0.165 | Glutamate decarboxylase inhibitor | 0.165 0.011 CID_27492 | CID_27492 | |
| 0.165 | 0.071 | 0.165 | Neurotensin receptor agonist | |||
| 0.097 | 0.004 | 0.097 | Cytokine production stimulant | |||
| 0.234 | 0.141 | 0.234 | Vasodilator, peripheral | |||
| 0.122 | 0.029 | 0.122 | Carbonic anhydrase VI inhibitor | |||
| 0.142 | 0.05 | 0.142 | Adenylate cyclase inhibitor | 0.109 0.076 CID_27492 | ||
| 0.133 | 0.045 | 0.159 | TRPA1 agonist | 0.159 0.025 CID_27492 | CID_27492 | |
| 0.149 | 0.061 | 0.149 | MAO inhibitor | |||
| 0.141 | 0.053 | 0.141 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.163 | 0.075 | 0.163 | Heat shock protein 90 alpha antagonist | |||
| 0.113 | 0.025 | 0.113 | ATPase (Vacuolar H+) inhibitor | |||
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | 0.071 0.065 CID_27492 | ||
| 0.15 | 0.064 | 0.15 | Neuropeptide Y1 antagonist | |||
| 0.104 | 0.018 | 0.104 | NMDA receptor agonist | |||
| 0.109 | 0.023 | 0.109 | Aminopeptidase I inhibitor | 0.073 0.049 CID_27492 | ||
| 0.123 | 0.037 | 0.123 | Anabolic | 0.11 0.049 CID_27492 | ||
| 0.12 | 0.035 | 0.12 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.193 | 0.109 | 0.193 | Peptidyltransferase inhibitor | 0.172 0.142 CID_27492 | ||
| 0.171 | 0.087 | 0.171 | Platelet adhesion inhibitor | |||
| 0.162 | 0.078 | 0.219 | Growth hormone agonist | 0.219 0.052 CID_27492 | CID_27492 | |
| 0.121 | 0.037 | 0.138 | Prolactin inhibitor | 0.138 0.028 CID_27492 | CID_27492 | |
| 0.124 | 0.041 | 0.124 | DOPA decarboxylase inhibitor | 0.116 0.05 CID_27492 | ||
| 0.095 | 0.013 | 0.095 | Heat shock protein 90 beta antagonist | |||
| 0.18 | 0.098 | 0.18 | Neurotrophic factor enhancer | |||
| 0.093 | 0.011 | 0.093 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.086 | 0.006 | 0.086 | Adenylate cyclase 1 inhibitor | 0.076 0.009 CID_27492 | ||
| 0.127 | 0.046 | 0.127 | Expectorant | |||
| 0.101 | 0.021 | 0.101 | Acetylcholine M2 receptor antagonist | |||
| 0.153 | 0.074 | 0.153 | Cholinergic | |||
| 0.152 | 0.073 | 0.157 | CF transmembrane conductance regulator agonist | 0.157 0.064 CID_27492 | CID_27492 | |
| 0.126 | 0.048 | 0.126 | Nav1.5 sodium channel blocker | |||
| 0.144 | 0.067 | 0.144 | Histone deacetylase SIRT1 inhibitor | |||
| 0.102 | 0.026 | 0.102 | Acetylcholine M4 receptor antagonist | |||
| 0.12 | 0.044 | 0.12 | Platelet activating factor alpha antagonist | |||
| 0.097 | 0.023 | 0.097 | Glycine receptor agonist | 0.077 0.043 CID_27492 | ||
| 0.093 | 0.019 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.033 CID_27492 | ||
| 0.174 | 0.1 | 0.224 | Antimitotic | 0.224 0.071 CID_27492 | CID_27492 | |
| 0.105 | 0.033 | 0.105 | Glutathione S-transferase inhibitor | 0.077 0.066 CID_27492 | ||
| 0.113 | 0.042 | 0.117 | MAP kinase kinase 1 inhibitor | 0.117 0.038 CID_27492 | CID_27492 | |
| 0.147 | 0.077 | 0.147 | Phospholipase A2 inhibitor | |||
| 0.1 | 0.031 | 0.1 | Keratolytic | |||
| 0.119 | 0.054 | 0.119 | Falcipain 3 inhibitor | 0.113 0.059 CID_27492 | ||
| 0.098 | 0.033 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.096 0.036 CID_27492 | ||
| 0.077 | 0.013 | 0.077 | Alpha-mannosidase inhibitor | 0.069 0.018 CID_27492 | ||
| 0.108 | 0.045 | 0.108 | Glutamate (mGluR7) agonist | |||
| 0.102 | 0.038 | 0.102 | Bromodomain-containing protein 2 inhibitor | |||
| 0.072 | 0.011 | 0.072 | Glucose-6-phosphate isomerase inhibitor | 0.071 0.012 CID_27492 | ||
| 0.094 | 0.034 | 0.094 | Interferon agonist | |||
| 0.103 | 0.043 | 0.103 | Bile acid receptor antagonist | |||
| 0.078 | 0.019 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.136 | 0.078 | 0.136 | Protein kinase stimulant | |||
| 0.071 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 CID_27492 | ||
| 0.077 | 0.02 | 0.077 | Beta 1 adrenoreceptor antagonist | 0.061 0.035 CID_27492 | ||
| 0.069 | 0.012 | 0.069 | Kainate receptor antagonist | 0.038 0.031 CID_27492 | ||
| 0.121 | 0.064 | 0.121 | Proteasome inhibitor | 0.101 0.086 CID_27492 | ||
| 0.061 | 0.004 | 0.061 | Glutamate (mGluR1a) agonist | 0.029 0.009 CID_27492 | ||
| 0.176 | 0.12 | 0.176 | Platelet antagonist | |||
| 0.08 | 0.024 | 0.08 | Interferon inducer | |||
| 0.114 | 0.059 | 0.114 | Acetylcholine release stimulant | |||
| 0.11 | 0.055 | 0.11 | MAO B inhibitor | |||
| 0.067 | 0.013 | 0.067 | Mannosidase inhibitor | 0.058 0.018 CID_27492 | ||
| 0.091 | 0.039 | 0.091 | Estrogen-related receptor beta agonist | |||
| 0.076 | 0.024 | 0.076 | Carbonic anhydrase VB inhibitor | |||
| 0.095 | 0.043 | 0.098 | Acetylcholine nicotinic antagonist | 0.098 0.04 CID_27492 | CID_27492 | |
| 0.079 | 0.027 | 0.079 | Acetylcholine M3 receptor antagonist | |||
| 0.062 | 0.012 | 0.068 | Microtubule stabilization | 0.068 0.008 CID_27492 | CID_27492 | |
| 0.137 | 0.087 | 0.137 | Heat shock protein 70 antagonist | |||
| 0.116 | 0.066 | 0.116 | Caspase 3 inhibitor | |||
| 0.141 | 0.091 | 0.141 | Interferon gamma antagonist | 0.125 0.122 CID_27492 | ||
| 0.127 | 0.077 | 0.127 | Amylase inhibitor | |||
| 0.076 | 0.026 | 0.076 | Acetylcholine M5 receptor antagonist | |||
| 0.073 | 0.023 | 0.204 | Urokinase inhibitor | 0.204 0.004 CID_27492 | CID_27492 | |
| 0.069 | 0.022 | 0.069 | Antimetabolite | 0.045 0.035 CID_27492 | ||
| 0.082 | 0.035 | 0.082 | Amidase inhibitor | |||
| 0.084 | 0.037 | 0.084 | MAP kinase kinase 7 inhibitor | 0.081 0.044 CID_27492 | ||
| 0.056 | 0.012 | 0.056 | Vascular adhesion protein 1 inhibitor | |||
| 0.067 | 0.024 | 0.067 | Sphingosine kinase 2 inhibitor | |||
| 0.099 | 0.056 | 0.099 | Potassium channel (Ca-activated) activator | |||
| 0.067 | 0.024 | 0.067 | Elastase inhibitor | |||
| 0.075 | 0.032 | 0.075 | Beta adrenoreceptor antagonist | |||
| 0.104 | 0.063 | 0.104 | Toll-Like receptor 4 antagonist | |||
| 0.059 | 0.018 | 0.059 | Leukocyte elastase inhibitor | |||
| 0.069 | 0.031 | 0.069 | Transcription factor AP-1 inhibitor | |||
| 0.059 | 0.021 | 0.059 | Adenosine deaminase inhibitor | |||
| 0.088 | 0.051 | 0.088 | mTOR complex 2 inhibitor | |||
| 0.051 | 0.014 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 CID_27492 | ||
| 0.049 | 0.012 | 0.049 | Glutamate (mGluR8) agonist | 0.047 0.014 CID_27492 | ||
| 0.107 | 0.07 | 0.107 | Cystathionine beta-synthase inhibitor | |||
| 0.041 | 0.005 | 0.041 | Vasopressin 1A agonist | 0.037 0.007 CID_27492 | ||
| 0.053 | 0.017 | 0.053 | GABA B receptor antagonist | |||
| 0.054 | 0.018 | 0.054 | Glutamate (mGluR4) antagonist | |||
| 0.101 | 0.065 | 0.101 | Nav1.1 sodium channel blocker | |||
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | |||
| 0.094 | 0.059 | 0.094 | Alcohol dehydrogenase inhibitor | |||
| 0.049 | 0.014 | 0.049 | Fumarate hydratase inhibitor | 0.034 0.024 CID_27492 | ||
| 0.049 | 0.015 | 0.049 | Arginase inhibitor | |||
| 0.037 | 0.003 | 0.037 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 CID_27492 | ||
| 0.037 | 0.003 | 0.037 | Carbonic anhydrase X inhibitor | 0.015 0.014 CID_27492 | ||
| 0.056 | 0.022 | 0.056 | Cholesterol esterase inhibitor | |||
| 0.049 | 0.015 | 0.049 | Diamine oxidase inhibitor | 0.039 0.024 CID_27492 | ||
| 0.157 | 0.124 | 0.157 | MAP kinase kinase 5 inhibitor | |||
| 0.059 | 0.026 | 0.059 | Immunoglobulin Fc receptor antagonist | |||
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR1a) antagonist | |||
| 0.084 | 0.051 | 0.084 | Glycine receptor antagonist | 0.077 0.062 CID_27492 | ||
| 0.049 | 0.017 | 0.049 | Potassium channel KCNQ activator | |||
| 0.049 | 0.017 | 0.049 | Delayed rectifier potassium channel activator | |||
| 0.052 | 0.02 | 0.052 | Histamine H2 receptor agonist | |||
| 0.048 | 0.016 | 0.051 | Kainate receptor agonist | 0.051 0.013 CID_27492 | CID_27492 | |
| 0.06 | 0.028 | 0.06 | Epithelial sodium channel blocker | |||
| 0.096 | 0.064 | 0.103 | Electrolyte absorption antagonist | 0.103 0.053 CID_27492 | CID_27492 | |
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | |||
| 0.072 | 0.041 | 0.072 | Carbonic anhydrase V inhibitor | |||
| 0.046 | 0.015 | 0.046 | Tryptase inhibitor | |||
| 0.036 | 0.005 | 0.036 | Acid ceramidase inhibitor | |||
| 0.042 | 0.011 | 0.042 | Uridine phosphorylase inhibitor | |||
| 0.066 | 0.034 | 0.066 | Histone deacetylase SIRT3 inhibitor | |||
| 0.04 | 0.01 | 0.04 | Glutamate (mGluR3) agonist | 0.033 0.02 CID_27492 | ||
| 0.099 | 0.068 | 0.099 | Gastric antisecretory | |||
| 0.059 | 0.029 | 0.059 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.046 CID_27492 | ||
| 0.071 | 0.041 | 0.071 | Glutamate (mGluR7) antagonist | 0.066 0.051 CID_27492 | ||
| 0.038 | 0.008 | 0.038 | Purinergic P2Y15 antagonist | 0.028 0.02 CID_27492 | ||
| 0.075 | 0.045 | 0.075 | Calcium channel L-type blocker | |||
| 0.051 | 0.022 | 0.051 | Geranyltranstransferase inhibitor | |||
| 0.041 | 0.012 | 0.041 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 CID_27492 | ||
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.054 | 0.026 | 0.054 | Potassium channel Kv1.3 blocker | |||
| 0.116 | 0.089 | 0.116 | Sodium channel (voltage-gated) blocker | |||
| 0.19 | 0.164 | 0.19 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.07 | 0.044 | 0.07 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.033 | 0.007 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 CID_27492 | CID_27492 | |
| 0.046 | 0.021 | 0.046 | Factor VIIa inhibitor | |||
| 0.036 | 0.011 | 0.036 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.045 | 0.02 | 0.045 | Membrane dipeptidase inhibitor | |||
| 0.092 | 0.068 | 0.092 | Xanthine oxidase inhibitor | |||
| 0.046 | 0.023 | 0.046 | Angiotensin AT1 receptor antagonist | |||
| 0.043 | 0.02 | 0.043 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.181 | 0.158 | 0.181 | Neuropeptide Y2 antagonist | |||
| 0.029 | 0.006 | 0.029 | Isoleucine-tRNA ligase inhibitor | |||
| 0.069 | 0.046 | 0.078 | Neuronal nicotinic receptor antagonist | 0.078 0.038 CID_27492 | CID_27492 | |
| 0.03 | 0.007 | 0.03 | 5 Hydroxytryptamine 4 agonist | |||
| 0.052 | 0.03 | 0.052 | HCV NS3/NS4A protease inhibitor | 0.051 0.031 CID_27492 | ||
| 0.037 | 0.015 | 0.037 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.145 | 0.124 | 0.145 | P-glycoprotein inhibitor | |||
| 0.082 | 0.062 | 0.082 | D-Ala-D-Ala ligase inhibitor | |||
| 0.025 | 0.004 | 0.025 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.041 | 0.021 | 0.041 | Bombesin 1 receptor antagonist | |||
| 0.093 | 0.075 | 0.093 | Urease inhibitor | |||
| 0.024 | 0.006 | 0.024 | Antibiotic Anthracycline-like | |||
| 0.047 | 0.029 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.087 | 0.069 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.022 | 0.005 | 0.022 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.03 | 0.014 | 0.03 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.056 | 0.04 | 0.056 | Pregnane X receptor antagonist | |||
| 0.042 | 0.026 | 0.042 | Dopamine D5 agonist | |||
| 0.024 | 0.009 | 0.024 | Neuraminidase (Influenza B) inhibitor | |||
| 0.095 | 0.08 | 0.095 | Monophenol monooxygenase inhibitor | |||
| 0.059 | 0.044 | 0.059 | Purinergic P2X1 antagonist | |||
| 0.112 | 0.098 | 0.112 | Cytokine production inhibitor | |||
| 0.023 | 0.009 | 0.023 | Factor XIII inhibitor | 0.023 0.01 CID_27492 | ||
| 0.047 | 0.033 | 0.047 | Benzodiazepine antagonist | |||
| 0.072 | 0.058 | 0.072 | Potassium channel (Tandem pore domain) blocker | |||
| 0.061 | 0.047 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.068 | 0.056 | 0.068 | Cathepsin G inhibitor | |||
| 0.016 | 0.004 | 0.016 | Angiotensin AT2 receptor agonist | |||
| 0.035 | 0.023 | 0.035 | Angiotensin II receptor antagonist | |||
| 0.11 | 0.098 | 0.11 | Sodium channel blocker | |||
| 0.092 | 0.08 | 0.092 | Mediator release inhibitor | |||
| 0.035 | 0.023 | 0.035 | Adenosine uptake inhibitor | |||
| 0.054 | 0.043 | 0.054 | Kallikrein 1 inhibitor | |||
| 0.019 | 0.008 | 0.019 | Telomerase stimulant | |||
| 0.042 | 0.031 | 0.042 | Guanylate cyclase inhibitor | |||
| 0.061 | 0.051 | 0.061 | Neuraminidase (influenza) inhibitor | |||
| 0.052 | 0.042 | 0.052 | Human rhinovirus A protease inhibitor | |||
| 0.039 | 0.029 | 0.039 | Dihydropteroate synthase inhibitor | |||
| 0.023 | 0.013 | 0.023 | Vasopressin 1 agonist | |||
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 CID_27492 | ||
| 0.035 | 0.026 | 0.035 | Antibiotic Aminoglycoside-like | |||
| 0.056 | 0.047 | 0.056 | Sphingosine kinase inhibitor | |||
| 0.073 | 0.064 | 0.073 | Chymotrypsin inhibitor | |||
| 0.031 | 0.022 | 0.031 | Cholesterol ester transfer protein antagonist | |||
| 0.033 | 0.024 | 0.033 | Calcitonin receptor agonist | |||
| 0.045 | 0.037 | 0.045 | Glutamate (mGluR group I) agonist | |||
| 0.026 | 0.018 | 0.026 | Thyroid hormone agonist | |||
| 0.077 | 0.069 | 0.077 | NMDA receptor antagonist | |||
| 0.029 | 0.021 | 0.029 | MAP3K8 inhibitor | |||
| 0.027 | 0.02 | 0.027 | Antidiuretic hormone agonist | |||
| 0.031 | 0.024 | 0.031 | Sirtuin 2 inhibitor | |||
| 0.048 | 0.041 | 0.048 | Factor IXa inhibitor | |||
| 0.127 | 0.121 | 0.147 | Melanin inhibitor | 0.147 0.086 CID_27492 | CID_27492 | |
| 0.048 | 0.042 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.056 | 0.051 | 0.056 | NMDA 2C receptor antagonist | |||
| 0.049 | 0.043 | 0.049 | Ribonucleotide reductase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.018 | 0.013 | 0.018 | Factor IX inhibitor | |||
| 0.035 | 0.031 | 0.035 | DNA gyrase subunit B inhibitor | |||
| 0.068 | 0.064 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | 0.088 0.042 CID_27492 | CID_27492 | |
| 0.041 | 0.037 | 0.041 | Dihydroorotase inhibitor | |||
| 0.046 | 0.042 | 0.046 | Squalene epoxidase inhibitor | |||
| 0.047 | 0.043 | 0.047 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.02 | 0.016 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.013 | 0.009 | 0.013 | Carbonic anhydrase XI inhibitor | |||
| 0.076 | 0.072 | 0.076 | Histamine N-methyltransferase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.016 | 0.013 | 0.016 | Vasopressin 2 agonist | |||
| 0.024 | 0.022 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.033 | 0.031 | 0.033 | Ceramide glucosyltransferase inhibitor | |||
| 0.026 | 0.024 | 0.026 | HCV NS5A inhibitor | |||
| 0.033 | 0.032 | 0.033 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.096 | 0.095 | 0.096 | Beta amyloid protein antagonist | |||
| 0.024 | 0.023 | 0.024 | Integrin alpha2beta1 antagonist | |||
| 0.045 | 0.044 | 0.045 | Beta 2 adrenoreceptor antagonist | |||
| 0.029 | 0.028 | 0.029 | Dipeptidyl peptidase II inhibitor | |||
| 0.081 | 0.08 | 0.081 | MAO A inhibitor | |||
| 0.031 | 0.03 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.014 | 0.015 | 0.019 | Nicotinic alpha4 receptor agonist | 0.019 0.008 CID_27492 | CID_27492 | |
| 0.023 | 0.025 | 0.026 | Complement factor 1s inhibitor | 0.026 0.017 CID_27492 | CID_27492 | |
| 0.077 | 0.08 | 0.12 | 3C-Like protease (SARS coronavirus) inhibitor | 0.12 0.019 CID_27492 | CID_27492 | |
| 0.015 | 0.022 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.01 CID_27492 | CID_27492 | |
| 0.063 | 0.071 | 0.076 | CYP2A6 inhibitor | 0.076 0.052 CID_27492 | CID_27492 | |
| 0.046 | 0.059 | 0.058 | Cathepsin B inhibitor | 0.058 0.037 CID_27492 | CID_27492 | |
| 0.041 | 0.057 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.031 CID_27492 | CID_27492 | |
| 0.052 | 0.07 | 0.057 | Caspase 9 inhibitor | 0.057 0.055 CID_27492 | CID_27492 | |
| 0.05 | 0.069 | 0.091 | Nitric oxide donor | 0.091 0.014 CID_27492 | CID_27492 | |
| 0.025 | 0.05 | 0.04 | Calpain 1 inhibitor | 0.04 0.01 CID_27492 | CID_27492 | |
| 0.027 | 0.055 | 0.033 | HCV polyprotein inhibitor | 0.033 0.028 CID_27492 | CID_27492 | |
| 0.01 | 0.045 | 0.042 | Dopamine autoreceptor agonist | 0.042 0.009 CID_27492 | CID_27492 | |
| 0.038 | 0.074 | 0.096 | Nicotinic receptor alpha4 subunit antagonist | 0.096 0.009 CID_27492 | CID_27492 | |
| 0.025 | 0.108 | 0.06 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 CID_27492 | CID_27492 | |
| 0.004 | 0.129 | 0.011 | 3C-Like protease (MERS coronavirus) inhibitor | 0.011 0.009 CID_27492 | CID_27492 | |
| 0.075 | 0.26 | 0.175 | Hepatoprotectant | 0.175 0.084 CID_27492 | CID_27492 | |
| 0.121 | 0.352 | 0.296 | Apoptosis antagonist | 0.296 0.088 CID_27492 | CID_27492 | |
| 0.016 | 0.534 | 0.146 | Epidermal growth factor receptor kinase inhibitor | 0.146 0.05 CID_27492 | CID_27492 | |
| 0.008 | 0.569 | 0.136 | Epidermal growth factor antagonist | 0.136 0.027 CID_27492 | CID_27492 | |
| 0.005 | 0.59 | 0.361 | Dopamine agonist | 0.361 0.005 CID_27492 | CID_27492 | |
| 0.003 | 0.919 | 0.16 | Focal adhesion kinase 1 inhibitor | 0.16 0.008 CID_27492 | CID_27492 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |